Endoscopic Vessel Harvesting System Market Size & Growth Forecast 2027–2036, By Segments (Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Endoscopic Vessel Harvesting System Market size was estimated at USD 171.3 million in 2026 and is projected to grow at a 3.33% CAGR from 2027 to 2036, crossing USD 237.7 million by 2036. The industry revenue for 2027 is assessed at USD 176.1 million.
Get more details on this report
Request Free Sample ReportEndoscopic Vessel Harvesting System Market Intelligence Snapshot
Regional Market Dynamics
- North America leads the market with established cardiac surgery volumes, advanced surgical infrastructure, and routine adoption of minimally invasive vessel harvesting technologies across hospitals.
- Asia Pacific is projected to grow at a 4.1% CAGR as hospitals invest in advanced surgical equipment and expand the adoption of minimally invasive cardiovascular procedures.
Segment Momentum
- Disposable systems lead due to strong infection-control compliance, consistent sterility assurance, and reduced reprocessing burden, making them preferred in routine surgical workflows.
- PAD is the fastest-growing application as minimally invasive vessel harvesting adoption expands beyond cardiac use, supporting broader vascular interventions requiring efficient conduit preparation.
Market Expansion Drivers
- Rising prevalence of cardiovascular diseases increasing demand for minimally invasive CABG procedures.
- Advancements in imaging-enabled EVH systems improving surgical precision and patient outcomes.
- Expanding geriatric population driving long-term growth in coronary bypass surgical interventions.
Leading Market Participants
- Prominent players in the endoscopic vessel harvesting system market include Getinge AB (Sweden), Terumo Corporation (Japan), Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), LivaNova PLC (United Kingdom), Saphena Medical, Inc. (United States), MAQUET Holding B.V. & Co. KG (Germany), CARDIO MEDICAL GmbH (Germany), Medical Instruments S.p.A. (Italy), Med Europe S.r.l. (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 171.3 million
- 2027 Estimated Market Size: USD 176.1 million.
- Projected Market Size: USD 237.7 million by 2036
- Growth Forecast: 3.33% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Disposable (Product) | Coronary Artery Disease (CAD) (Application)
- Emerging Opportunity Segment: Re-usable (Product) | Peripheral Artery Disease (PAD) (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of cardiovascular diseases increasing demand for minimally invasive CABG procedures
The endoscopic vessel harvesting system market is supported by the continued burden of cardiovascular disease, which contributes to demand for coronary artery bypass grafting procedures among patients requiring surgical revascularization. Endoscopic vessel harvesting provides surgeons with a minimally invasive approach to obtaining suitable graft vessels while reducing the size and extent of incisions compared with traditional open harvesting techniques. This approach can support reduced tissue disruption, improved postoperative recovery characteristics, and better cosmetic outcomes, making it relevant to the broader movement toward less invasive cardiac surgery. As healthcare systems focus on improving surgical efficiency and patient recovery while managing the needs of cardiovascular patients, the adoption of specialized vessel-harvesting technologies remains an important consideration in CABG procedures.
Advancements in imaging-enabled EVH systems improving surgical precision and patient outcomes
Technological progress in imaging and visualization is strengthening the endoscopic vessel harvesting system market by improving the surgeon's ability to identify, dissect, and preserve target vessels during minimally invasive procedures. Enhanced visualization can provide clearer views of anatomical structures and support more controlled vessel harvesting, helping surgical teams manage complex anatomical conditions while reducing unnecessary tissue handling. Integration of improved imaging capabilities with ergonomic instruments and refined endoscopic techniques can also contribute to more consistent procedural performance and facilitate adoption among cardiac surgery centers seeking advanced minimally invasive approaches. Continued development of visualization-enabled systems is therefore increasing the clinical utility of EVH technologies in settings where precision and vessel quality are critical to surgical outcomes.
Expanding geriatric population driving long-term growth in coronary bypass surgical interventions
An expanding geriatric population is contributing to the endoscopic vessel harvesting system market because older adults represent an important patient group requiring cardiovascular diagnosis and intervention, including coronary bypass surgery when clinically appropriate. Age-related accumulation of cardiovascular risk factors can increase the need for revascularization procedures, while healthcare providers increasingly emphasize surgical approaches that support recovery and minimize procedural burden for older patients. Endoscopic harvesting can offer a less invasive method of obtaining graft vessels, potentially making it attractive in surgical pathways where limiting wound-related complications and supporting postoperative mobility are important considerations. The growing need to manage cardiovascular conditions among aging populations is consequently reinforcing demand for technologies that can support efficient and minimally invasive graft-vessel preparation.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of cardiovascular diseases increasing demand for minimally invasive CABG procedures | 1.90% | High | North America, Europe | High | Near Term |
| Advancements in imaging-enabled EVH systems improving surgical precision and patient outcomes | 1.60% | High | North America, Asia Pacific | Medium | Mid Term |
| Expanding geriatric population driving long-term growth in coronary bypass surgical interventions | 1.30% | Moderate | Europe, North America | High | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America led the endoscopic vessel harvesting system market in 2026, supported by advanced cardiovascular care infrastructure, widespread adoption of minimally invasive surgical techniques, and strong demand for technologies that can improve surgical efficiency and patient recovery. Hospitals and cardiac centers in the region increasingly favor procedures that reduce surgical trauma while maintaining effective vessel harvesting outcomes, supporting the use of endoscopic approaches in coronary artery bypass procedures. The presence of specialized surgical expertise, established healthcare systems, and continued investment in advanced medical equipment further strengthens adoption. Growing awareness of the clinical and operational benefits associated with minimally invasive vessel harvesting is also helping sustain the region's leading market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected as the fastest-growing region, supported by expanding healthcare infrastructure, improving access to specialized cardiovascular treatment, and increasing adoption of minimally invasive surgical procedures. Rising demand for advanced cardiac care is encouraging hospitals to modernize operating facilities and introduce technologies that can improve procedural outcomes and recovery experiences. Healthcare investment, expansion of specialized medical centers, and growing clinical awareness of endoscopic vessel harvesting are creating additional opportunities across developing healthcare markets. As medical professionals increasingly adopt advanced surgical techniques and healthcare systems place greater emphasis on efficient, less invasive procedures, demand for endoscopic vessel harvesting systems is expected to gain significant momentum in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Surgical Workflow OptimizationGermany advances the endoscopic vessel harvesting system market through continued investment in precision surgical technologies. Healthcare providers focus on equipment that enhances procedural efficiency, improves graft quality, and supports standardized cardiovascular surgery practices.
France 🇫🇷
Clinical Quality EnhancementFrance promotes the endoscopic vessel harvesting system market by emphasizing patient-centered surgical care and improved procedural outcomes. Hospitals invest in technologies that minimize tissue damage while supporting efficient cardiovascular surgical practices.
Italy 🇮🇹
Cardiac Procedure EfficiencyItaly supports the endoscopic vessel harvesting system market through wider adoption of minimally invasive cardiac surgery techniques. Healthcare facilities prioritize systems that enhance surgical precision, optimize operating room workflows, and improve postoperative recovery experiences.
Japan 🇯🇵
Precision Surgical AdoptionJapan supports the endoscopic vessel harvesting system market with demand for minimally invasive procedures and advanced operating room technologies. Medical institutions emphasize reliable imaging, surgeon training, and consistent clinical outcomes in cardiovascular interventions.
South Korea 🇰🇷
Advanced Hospital IntegrationSouth Korea is strengthening the endoscopic vessel harvesting system market through modernization of cardiac surgery infrastructure. Healthcare providers adopt systems that improve procedural precision, reduce recovery time, and integrate efficiently with minimally invasive surgical workflows.
United States 🇺🇸
Minimally Invasive Cardiac CareThe U.S. endoscopic vessel harvesting system market benefits from broad adoption of minimally invasive cardiac surgery techniques. Hospitals prioritize technologies that improve procedural consistency, reduce surgical trauma, and support faster patient recovery within cardiovascular care programs.
Segment Leadership and Growth Trends
Endoscopic Vessel Harvesting System Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Disposable (Largest Segment) vs Re-usable (Fastest-Growing Segment)
The disposable segment held the largest share of the endoscopic vessel harvesting system market in 2026, supported by its role in maintaining procedural sterility and reducing the risk of cross-contamination during vascular harvesting procedures. Single-use devices eliminate the need for complex reprocessing and sterilization workflows, which can improve operating room efficiency and simplify inventory management. Their consistent performance and readiness for immediate use also support adoption in hospitals and surgical centers seeking streamlined procedural protocols. In addition, growing emphasis on infection control and standardized surgical practices continues to reinforce demand for disposable harvesting systems.
Re-usable systems are gaining momentum as healthcare providers increasingly evaluate equipment utilization, long-term operating economics, and waste reduction. These systems can be reprocessed for repeated procedures, making them attractive for facilities with established sterilization infrastructure and consistent procedural volumes. Greater attention to resource efficiency and healthcare sustainability is also encouraging consideration of re-usable technologies where appropriate. Improvements in device durability, reprocessing compatibility, and clinical workflow integration can further strengthen adoption as providers seek to balance procedural performance with operational efficiency.
Application Segment Analysis: Coronary Artery Disease (CAD) (Largest Segment) vs Peripheral Artery Disease (PAD) (Fastest-Growing Segment)
In the endoscopic vessel harvesting system market, the coronary artery disease (CAD) segment held the largest share in 2026, reflecting the established use of vascular harvesting procedures in coronary revascularization. Endoscopic techniques enable clinicians to obtain suitable blood vessels through less invasive approaches while supporting reduced tissue disruption compared with conventional harvesting methods. The continued use of coronary bypass procedures and increasing emphasis on improving postoperative recovery contribute to sustained demand for efficient vessel harvesting technologies. Greater adoption of minimally invasive surgical techniques is also supporting the integration of endoscopic systems into cardiovascular care pathways.
The peripheral artery disease (PAD) segment is experiencing faster adoption as healthcare providers place greater emphasis on minimally invasive approaches for peripheral vascular interventions. Endoscopic vessel harvesting can support procedures requiring vascular conduits while potentially improving wound management and facilitating recovery. Rising clinical attention to peripheral vascular disease, together with the broader shift toward less invasive surgical techniques, is encouraging interest in technologies that can improve procedural efficiency and patient management. Expanding capabilities for peripheral applications are expected to further support demand for vessel harvesting systems within this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Disposable, Re-usable | Disposable | Re-usable |
| Application | Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD) | Coronary Artery Disease (CAD) | Peripheral Artery Disease (PAD) |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the endoscopic vessel harvesting system market:
1. Getinge AB (Sweden)
2. Terumo Corporation (Japan)
3. Olympus Corporation (Japan)
4. KARL STORZ SE & Co. KG (Germany)
5. LivaNova PLC (United Kingdom)
6. Saphena Medical Inc. (United States)
7. MAQUET Holding B.V. & Co. KG (Germany)
8. CARDIO MEDICAL GmbH (Germany)
9. Medical Instruments S.p.A. (Italy)
10. Med Europe S.r.l. (Italy)
Surgical precision requirements are driving steady evolution in the endoscopic vessel harvesting system market, where minimally invasive approaches are becoming increasingly central to procedural advancement. Device refinement is focused on improving harvesting efficiency while reducing patient trauma. In the endoscopic vessel harvesting system market, continuous innovation in visualization and instrumentation is strengthening surgical outcomes and procedural reliability.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Getinge AB (Sweden) | |||||||
| Terumo Corporation (Japan) | |||||||
| Olympus Corporation (Japan) | |||||||
| KARL STORZ SE & Co. KG (Germany) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Saphena Medical Inc. (United States) | |||||||
| MAQUET Holding B.V. & Co. KG (Germany) | |||||||
| CARDIO MEDICAL GmbH (Germany) | |||||||
| Medical Instruments S.p.A. (Italy) | |||||||
| Med Europe S.r.l. (Italy). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Getinge | May-24 | Getinge organized a Vessel Harvesting (EVH) Summit in Singapore, bringing together clinicians to discuss surgical ergonomics, patient considerations, and procedural best practices. The initiative supports clinical engagement and knowledge exchange, reinforcing Getinge’s ecosystem positioning within endoscopic vessel harvesting procedures. |
| Getinge | Mar-24 | Getinge obtained U.S. FDA 510(k) clearance for its Vasoview Hemopro 3 Endoscopic Vessel Harvesting system, strengthening its minimally invasive cardiovascular surgery portfolio. The approval is positioned to expand clinical adoption by enhancing surgical efficiency and reinforcing the company’s regulatory footprint in EVH technologies. |
| Getinge / Maquet | 2024 | Getinge’s Maquet division experienced a Class I recall of its VasoView HemoPro endoscopic vessel harvesting device due to risks linked to silicone debris-related injuries. The incident triggered FDA communication on potential device shortages, highlighting regulatory and supply continuity risks impacting EVH system availability in cardiovascular surgical applications. |
| COMBINE-CT | Dec-23 | COMBINE-CT received USD 7.28 million in funding from the Innovative Health Initiative to advance diagnostic and treatment approaches for coronary artery disease. The initiative is expected to improve clinical accuracy and treatment pathways, indirectly supporting demand for advanced cardiovascular and endoscopic vessel harvesting procedures. |
| LivaNova PLC | Apr-22 | LivaNova PLC introduced the Essenz Patient Monitor in the U.S. and Europe following FDA 510(k) clearance and CE Mark approval. The system is designed to enhance cardiopulmonary bypass procedures through patient-tailored monitoring, improving clinical efficiency in cardiovascular surgical workflows associated with vessel harvesting procedures. |
| CardioPrecision | Sep-21 | CardioPrecision launched its CoreVista device suite for use in endoscopic vessel harvesting during coronary artery bypass grafting procedures. The introduction expands minimally invasive surgical tool availability, supporting procedural efficiency and contributing to broader adoption of EVH techniques in cardiac surgery environments. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Endoscopic Vessel Harvesting System Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Healthcare Facility Type | Hospitals, Ambulatory Surgical Centers, Specialty Cardiac Centers |
| Procedure Setting | Inpatient Procedures, Outpatient Procedures, Ambulatory Surgical Procedures |
| Reimbursement Category | Publicly Reimbursed Procedures, Privately Insured Procedures, Self-Pay Procedures |
Endoscopic Vessel Harvesting System Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Minimally Invasive Cardiac Surgery Adoption |
|
| Hospital Procedure Economics Analysis |
|
| Surgeon Adoption and Training Landscape |
|
Need a different cut of the data?
Request Custom ResearchHow big is the endoscopic vessel harvesting system market?
How is the endoscopic vessel harvesting system industry projected to perform over the next decade?
How is rising cardiovascular disease prevalence influencing EVH system adoption in surgical care?
How are imaging advancements improving clinical adoption of endoscopic vessel harvesting systems?
Why do Disposable systems dominate the endoscopic vessel harvesting market?
What is driving growth in Peripheral Artery Disease (PAD) applications?
Why is North America the leading region in the endoscopic vessel harvesting system market?
What is fueling endoscopic vessel harvesting system market growth in Asia Pacific?
Who are the major participants shaping the endoscopic vessel harvesting system landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization